Trial of experimental AIDS drug to be continued, with revisions.
D000163:Acquired Immunodeficiency Syndrome; D000529:Complementary Therapies; D064420:Drug-Related Side Effects and Adverse Reactions; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D009026:Mortality; D010344:Patient Advocacy; D004364:Pharmaceutical Preparations; D012106:Research; D012306:Risk; D018570:Risk Assessment; D012495:San Francisco; D012926:Social Control, Formal; D036302:Therapeutic Human Experimentation; D015978:Trichosanthin; D014481:United States; D014486:United States Food and Drug Administration
Biomedical and Behavioral Research; Health Care and Public Health; Legal Approach; Popular Approach/Source